The vision of Antare and The ALP. I SPAC announces that they have reached an agreement for the two companies to merge, The reason for the merger is to offer support and an acceleration of the growth trajectory of Antare`s vision from creation to the present day. Alp. I will invest 70 million euros and, after the acquisition, I will take over about 12% of the company based in Brescia. The general approval meeting for the business combination will take place in February 2019. In line with the vision of Anta and its shareholders, it was decided to leave the number of warrants and transformation shares for investors unchanged, despite the 30% reduction in the ALP. I investments (which would generally have led to a proportional reduction in warrants), which increased leverage in favour of any ordinary investor. Governance: You understand and accept that this agreement is governed and interpreted in accordance with the laws of the United States of America, the State of North Carolina, County of Buncombe, without the principles of legal conflict coming into force. In the event that a provision of this Agreement is found to be unlawful, consider and accept that this provision may be dissociated from this Agreement without impairing the applicability of all other provisions.
B, the parties have family ties). see ProPublica.org series of investigative articles Copyright: The entire content of this site is subject to copyright protection. Copyright © 2007-2015 ALP Life Sciences, LLC (ALP). The contents of ALP sites may only be copied, reproduced or disseminated for non-commercial individual references with all protected property or other ownership modes. You cannot copy, view, download, distribute, edit, reproduce, publish or retransmit information, texts or documents contained on this website without ALP`s explicit written consent, or copy, view, download, edit, reproduce, reproduce or retransmit other information, texts or documents in paper or paper format. None of these terms should be construed as part of a license or right under a patent or trademark of ALP or a third party.